4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-26-004909
CVP, TAVR sold 2,038 shares at an average $83.49 ($170,160)
- CVP, TAVR acquired 2,038 shares (option exercise)
- CVP, TAVR gave up 252 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lippis Daniel J. · CVP, TAVR
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,019 | $59.26 | $60,383 | 34,952.91 | D |
| 2026-05-01 | Sale : show line 2 in the form 10b5-1 | −19 | $83.99 | $1,596 | 34,933.91 | D |
| 2026-05-01 | Sale : show line 3 in the form 10b5-1 | −1,000 | $82.99 | $82,989 | 33,933.91 | D |
| 2026-05-03 | Shares withheld for taxes : show line 4 in the form 10b5-1 | −252 | $83.98 | $21,163 | 33,681.91 | D |
| 2026-05-04 | Exercise or conversion : show line 5 in the form 10b5-1 | +1,019 | $59.26 | $60,383 | 34,700.91 | D |
| 2026-05-04 | Sale : show line 6 in the form 10b5-1 | −1,019 | $83.98 | $85,576 | 33,681.91 | D |
| Open-market sales · 2,038 sh · avg $83.49 · $170,160 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-01 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −1,019 | 1,019 | D |
| 2026-05-04 | Exercise or conversion : show line 8 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −1,019 | 0 | D |
Loading xslF345X06/doc4.xml…